Skip to content

Modification to: Monojet Prefill 0.9% Sodium Chloride Flush Syringe, Monojet Prefill Heprin Lock Flush Syringe

by Tyco Healthcare

510(k) K032438

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

4 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK032438 Date30 Jun 2004ClearedStatusActive

Recalls

26 recalls · 4 ongoing · FDA

    • Ongoing Z-0119-2022 FDA Class I initiated 19 Aug 2021

    Monoject 0.9% Sodium Chloride Flush Syringe Manufactured by Cardinal Health and placed into kits. Potential for the plunger to draw back after air has been expelled and reintroduce air back into the syringe.

  • 3 recalls, same reason

    • Ongoing Z-2284-2021 FDA Class I initiated 4 Aug 2021
    • Ongoing Z-2285-2021 FDA Class I initiated 4 Aug 2021
    • Ongoing Z-2286-2021 FDA Class I initiated 4 Aug 2021

    Potential for the plunger to draw back after the air has been expelled and reintroduce air back into the syringe.

  • 9 recalls, same reason

    • Terminated Z-2182-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2183-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2185-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2179-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2181-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2178-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2180-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2186-2013 FDA Class II initiated 16 Aug 2013
    • Terminated Z-2184-2013 FDA Class II initiated 16 Aug 2013

    Monoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin

  • 6 recalls, same reason

    • Terminated Z-0568-2011 FDA Unclassified (pre-2012) initiated 15 Nov 2010
    • Terminated Z-0567-2011 FDA Unclassified (pre-2012) initiated 15 Nov 2010
    • Terminated Z-0566-2011 FDA Unclassified (pre-2012) initiated 15 Nov 2010
    • Terminated Z-0569-2011 FDA Unclassified (pre-2012) initiated 15 Nov 2010
    • Terminated Z-0564-2011 FDA Unclassified (pre-2012) initiated 15 Nov 2010
    • Terminated Z-0565-2011 FDA Unclassified (pre-2012) initiated 15 Nov 2010

    The heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.

  • 6 recalls, same reason

    • Terminated Z-1600-2008 FDA Unclassified (pre-2012) initiated 28 Mar 2008 on shared 510(k) K032438
    • Terminated Z-1598-2008 FDA Unclassified (pre-2012) initiated 28 Mar 2008 on shared 510(k) K032438
    • Terminated Z-1602-2008 FDA Unclassified (pre-2012) initiated 28 Mar 2008 on shared 510(k) K032438
    • Terminated Z-1595-2008 FDA Unclassified (pre-2012) initiated 28 Mar 2008 on shared 510(k) K032438
    • Terminated Z-1599-2008 FDA Unclassified (pre-2012) initiated 28 Mar 2008 on shared 510(k) K032438
    • Terminated Z-1596-2008 FDA Unclassified (pre-2012) initiated 28 Mar 2008 on shared 510(k) K032438

    Scientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant

    • Terminated Z-1597-2008 FDA Unclassified (pre-2012) initiated 28 Mar 2008 on shared 510(k) K032438

    Scientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant Tyco Healthcare, Mansfield, MA 02048

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
NGT
Device Class
Class II
Regulation
21 CFR Part 880.5200
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Other devices from Tyco Healthcare

See all devices from Tyco Healthcare →